Skip to main content

Table 1 Characteristics of the population at inclusion

From: A prospective hospital study of alcohol use disorders, comorbid psychiatric conditions and withdrawal prognosis

N = 330, unless otherwise indicated Mean ± SD (n) or  % (n)
Age (years) 45.2 ± 10.2
Sex-ratio (male/female) 3.6 (258/72)
Single/divorced/widowed (324) 69.1 % (224)
Lifestyle (324)
 Couple 31.5 % (102)
 Living alone 39.1 % (127)
 Other (family, friends…) 29.4 % (97)
With a professional activity 55.4 % (174)
Resources (327)
 Own or from family 67.9 (222)
 Social 32.1 (105)
Smokers 80.2 % (186)
With psychiatric co-morbidity 60.9 % (200)
Type of psychiatric comorbidity
 None 39.1 % (129)
 Dementia 1.5 % (5)
 Psychosis 4.6 % (15)
 Mood and affective disorder 30.6 % (101)
 Anxiety disorder 5.5 % (18)
 Personality disorder 26.1 % (87)
With somatic comorbidity 7.6 % (25)
Global Assessment of Functioning 49.14 ± 15.60
AUDIT (312) 26.9 ± 7.7
 Risk use (score ≤7) 2.2 (7)
 Harmful use (7< score <13) 2.2 (7)
 Dependence (score ≥13) 95.5 (298)
BDI score (308) 13.5 ± 7.1
BDI categories
 Absent 5.8 (18)
 Slight 16.2 (50)
 Moderate 41.6 (128)
 Severe 36.4 (112)
MCV (µm3) 97.9 ± 6.2
 % >normal values (n) 55.9 (181)
SGOT (UI/L) 47.4 ± 53.5
 % >normal values (n) 39.3 (129)
SGPT (UI/L) 42.5 ± 41.5
 % >normal values (n) 41.5 (136)
GGT (UI/L) (mean ± SD) 222.7 ± 408.2
 % >normal values (n) 61.6 (202)
Current psychotropic treatment
 Neuroleptics 14.2 % (47)
 Atypical antipsychotics 14.5 % (48)
 Thymoregulators 7.8 % (26)
 Antidepressants 52.7 % (174)
 Anxiolytics 90 (297)
 Benzodiazepines 88.4 % (292)
 Related to benzodiazepines 23.0 % (76)
  1. AUDIT alcohol use disorder identification test, BDI Beck Depression Inventory, GGT gamma-glutamyl transferase, MCV mean corpuscular volume, SGOT serum glutamate oxaloacetate tranasminase, SGPT serum glutamic pyruvic transaminase